New england biolabs:1105931 [18-002500]
Ended Awarded Last action
- Contract number
- HHSN26400002
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,630
Award facts
- Contract value 100% obligated
- $3,630.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Fixed Price Redetermination
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$145 | |
| Funding Only Action | $0 | |
| Original award | $3,775 |
About this award
New England Biolabs, Inc. received a Blanket Purchase Agreement (BPA) call order valued at $3,630.00 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The award was issued on March 15, 2018, with an ultimate completion date of March 30, 2023, and utilized fixed-price redetermination pricing. As the prime contractor, New England Biolabs supplied molecular biology products and reagents essential for life sciences research conducted at NIAMS facilities in Bethesda, Maryland. This contract included no set-aside designation and represents a call order against the company's established BPA with the NIH system.
New England Biolabs is a leading manufacturer of specialized molecular biology reagents, kits, and enzymes based in Ipswich, Massachusetts. The company's primary deliverables for federal agencies include NEBNext library preparation kits, RNA and DNA sequencing reagents, PCR reagents, and various enzymatic products used in genomics and infectious disease research. The company maintains significant standing agreements with multiple NIH institutes and has consistently provided high-quality biological materials supporting critical biomedical investigations across the federal research enterprise.
Quick answers
Who was awarded contract HHSN26400002?
HHSN26400002 was awarded to New England Biolabs, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on March 15, 2018.
How much is contract HHSN26400002 worth?
The government has obligated $3,630 on HHSN26400002.
Is contract HHSN26400002 an order under another contract?
Yes. HHSN26400002 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26400002 competed?
The extent of competition for HHSN26400002 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award